Cargando…
Regulation of Murine Ovarian Epithelial Carcinoma by Vaccination against the Cytoplasmic Domain of Anti-Müllerian Hormone Receptor II
Anti-Müllerian hormone receptor, type II (AMHR2), is a differentiation protein expressed in 90% of primary epithelial ovarian carcinomas (EOCs), the most deadly gynecologic malignancy. We propose that AMHR2 may serve as a useful target for vaccination against EOC. To this end, we generated the recom...
Autores principales: | Sakalar, Cagri, Mazumder, Suparna, Johnson, Justin M., Altuntas, Cengiz Z., Jaini, Ritika, Aguilar, Robert, Prasad, Sathyamangla V. Naga, Connolly, Denise C., Tuohy, Vincent K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651663/ https://www.ncbi.nlm.nih.gov/pubmed/26618181 http://dx.doi.org/10.1155/2015/630287 |
Ejemplares similares
-
Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II
por: Mazumder, Suparna, et al.
Publicado: (2020) -
Correction: Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II
por: Mazumder, Suparna, et al.
Publicado: (2022) -
Uroplakin Peptide-Specific Autoimmunity Initiates Interstitial Cystitis/Painful Bladder Syndrome in Mice
por: Izgi, Kenan, et al.
Publicado: (2013) -
Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer
por: Tuohy, Vincent K., et al.
Publicado: (2016) -
Cytoplasmic-predominant Pten increases microglial activation and synaptic pruning in a murine model with autism-like phenotype
por: Sarn, Nicholas, et al.
Publicado: (2020)